Cited by 254Acute Myocardial Infarction ResearchPlatelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction

Frossard, Martin, Fuchs, Ingrid, Leitner, Judith M., Hsieh, Kety, Vlcek, Marianne, Losert, Heidrun, Domanovits, Hans, Schreiber, Wolfgang, Laggner, Anton N., Jilma, Bernd·2004·Circulation

DOI 10.1161/01.cir.0000141575.92958.9c

Open this paper in CoChat — free account

Abstract

Background— Platelet activation is a hallmark of acute coronary syndromes. Numerous lines of evidence suggest a mechanistic link between von Willebrand factor or platelet hyperfunction and myocardial damage in patients with acute coronary syndromes. Thus, we assessed whether platelet function under high shear rates (collagen adenosine diphosphate closure times [CADP-CTs]) measured with the platelet function analyzer (PFA-100) may be enhanced in patients with myocardial infarction (MI) and whether it may predict the extent of myocardial damage as measured by creatine kinase (CK-MB) or troponin T (TnT) levels. Methods and Results— Patients with acute chest pain or symptoms suggestive of acute coronary syndromes (n=216) were prospectively examined at an emergency department. CADP-CT was significantly shorter in patients with MI, particularly in those with an ST-segment-elevation MI (STEMI) compared with the other patient groups (unstable angina, stable coronary artery disease, or controls). Furthermore, CADP-CT and collagen epinephrine–CT at presentation were independent predictors of myocardial damage as measured by CK-MB or TnT. Patients with MI whose CADP-CT values fell in the first quartile had 3-fold higher CK-MB and TnT levels than those in the fourth quartile. Conclusions— Patients with STEMI have significantly enhanced platelet function when measured under high shear rates. CADP-CT is an independent predictor of the severity of MI, as measured by markers of cardiac necrosis. Measurement of platelet function with the PFA-100 may help in the risk stratification of patients presenting with MI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000141575.92958.9c

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E., Green, L. A., Hand, M. M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,348
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M., Penn, M. S., Lente, F. V., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,071
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article
D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 844
1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B. J., Russell, R. O., Smith, E. E., et al. (1999) · Circulation · doi:10.1161/01.cir.100.9.1016 · Cited by 742
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Lip, G. Y. H. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00039-4 · Cited by 457
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 427

Show all 36 references

Research works printed but not linked: 12

10.1161/circ.100.6.614 · DOI
10.1161/circ.94.6.1239 · DOI
10.1161/circ.100.20.2045 · DOI
10.1161/circ.104.23.2767 · DOI
10.1182/blood.V65.4.823.823 · DOI
10.1161/circ.99.5.608 · DOI
10.1161/circ.100.9.1016 · DOI
2000, Br J Haematol, 111, 733
10.1161/circ.102.19.2329 · DOI
10.1161/circ.101.13.1619 · DOI
2003, J Thromb Haemost, 1, OC328.
2002, Rev Cardiovasc Med, 3, S13

Sorted by citations

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment The ISAR-REACT 2 Randomized Trial
Kastrati, A. (2006) · JAMA · doi:10.1001/jama.295.13.joc60034 · Cited by 748
Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol
Erlund, I., Koli, R., Alfthan, G., Marniemi, J., Puukka, P., Mustonen, P., Mattila, P., & Jula, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.323 · Cited by 445
Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function
Hayward, C. P. M., Harrison, P., Cattaneo, M., Ortel, T. L., & Rao, A. K. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01771.x · Cited by 405
Von Willebrand Factor in Cardiovascular Disease
Spiel, A. O., Gilbert, J. C., & Jilma, B. (2008) · Circulation · doi:10.1161/circulationaha.107.722827 · Cited by 403
Self-citation
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
Platelet Function Testing in Cardiovascular Diseases
Michelson, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000147228.29325.f9 · Cited by 317
Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction
Valgimigli, M., Percoco, G., Malagutti, P., Campo, G. C., Ferrari, F., Barbieri, D., Cicchitelli, G., McFadden, E. P., Merlini, F., ANSANI, L., et al. (2005) · JAMA · doi:10.1001/jama.293.17.2109 · Cited by 306
Clinical Utility of the PFA-100
Favaloro, E. J. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1145254 · Cited by 278
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction The MULTISTRATEGY Randomized Trial
Valgimigli, M. (2008) · JAMA · doi:10.1001/jama.299.15.joc80026 · Cited by 266
Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm
Raupach, T., Schäfer, K., Konstantinides, S., & Andreas, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi601 · Cited by 251
Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
Ferlitsch, M., Reiberger, T., Hoke, M., Salzl, P., Schwengerer, B., Ulbrich, G., Payer, B. A., Trauner, M. A., Peck‐Radosavljevic, M., & Ferlitsch, A. (2012) · Hepatology · doi:10.1002/hep.25806 · Cited by 210
Measuring antiplatelet drug effects in the laboratory
Harrison, P., Frelinger, A. L., Furman, M. I., & Michelson, A. D. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.11.012 · Cited by 189
Different methodologies for evaluating the effect of clopidogrel on platelet function in high‐risk coronary artery disease patients
Paniccia, R., Antonucci, E., Gori, A. M., Marcucci, R., Giglioli, C., Antoniucci, D., Gensini, G. F., Abbate, R., & Prisco, D. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02656.x · Cited by 187
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
Cattaneo, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02498.x · Cited by 179
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N‐oxide‐generating pathway, modulates platelet responsiveness and thrombosis risk
Zhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Clopidogrel Withdrawal Is Associated With Proinflammatory and Prothrombotic Effects in Patients With Diabetes and Coronary Artery Disease
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jiménez‐Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1394 · Cited by 158
Immunothrombosis and thromboinflammation in host defense and disease
Martinod, K., & Deppermann, C. (2020) · Platelets · doi:10.1080/09537104.2020.1817360 · Cited by 155
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention
Campo, G. C., Valgimigli, M., Gemmati, D., Percoco, G., Tognazzo, S., Cicchitelli, G., Catozzi, L., Malagutti, P., Anselmi, M., Vassanelli, C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.085 · Cited by 138
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction
Li, J., Sun, S., Zhu, D., Mei, X., Lyu, Y., Huang, K., Li, Y., Liu, S., Wang, Z., Hu, S., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065005 · Cited by 128
Multiscale prediction of patient-specific platelet function under flow
Flamm, M. H., Colace, T. V., Chatterjee, M. S., Jing, H., Zhou, S., Jaeger, D. T. L., Brass, L. F., Sinno, T. R., & Diamond, S. L. (2012) · Blood · doi:10.1182/blood-2011-10-388140 · Cited by 125
Platelet Function in Aging
Blanc, J. L., & Lordkipanidzé, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00109 · Cited by 133
Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism
Homoncik, M., Gessl, A., Ferlitsch, A., Jilma, B., & Vierhapper, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2644 · Cited by 122
Self-citation
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
Fuchs, I., Frossard, M., Spiel, A. O., Riedmüller, E., Laggner, A. N., & Jilma, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02239.x · Cited by 120
Self-citation
Indices of platelet activation and the stability of coronary artery disease
Linden, M. D., Furman, M. I., Frelinger, A. L., Fox, M. L., Barnard, M. R., LI, Y., Przyklenk, K., & Michelson, A. D. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02462.x · Cited by 118
Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Patti, G., Bárczi, G., Orlic, D. N., Mangiacapra, F., Colonna, G., Pasceri, V., Barbato, E., Merkely, B. P., Edes, I. F., Ostojić, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.044 · Cited by 113
Influence of Aspirin Resistance on Platelet Function Profiles in Patients on Long-Term Aspirin and Clopidogrel After Percutaneous Coronary Intervention
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jiménez‐Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.106 · Cited by 113
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction
Gargiulo, G., Esposito, G., Avvedimento, M., Nagler, M., Minuz, P., Campo, G. C., Gragnano, F., Manavifar, N., Piccolo, R., Tebaldi, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046928 · Cited by 98
The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests
Elsenberg, E. H. A. M., van de Wal, R. M. A., Zomer, C. A., Bouman, H. J., Verheugt, F. W. A., ten Berg, J. M., Hackeng, C. M., & van Werkum, J. W. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0285 · Cited by 97
Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With Clopidogrel
Małek, Ł. A., Kisiel, B. M., Śpiewak, M., Grabowski, M., Filipiak, K. J., Kostrzewa, G., Huczek, Z., Płoski, R., & Opolski, G. (2008) · Circulation Journal · doi:10.1253/circj.72.1165 · Cited by 94
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs
Gresele, P., Momi, S., & Guglielmini, G. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.030 · Cited by 97
Effects of Aspirin Responsiveness and Platelet Reactivity on Early Vein Graft Thrombosis After Coronary Artery Bypass Graft Surgery
Gluckman, T. J., McLean, R. C., Schulman, S. P., Kickler, T. S., Shapiro, E. P., Conte, J. V., McNicholas, K. W., Segal, J. B., & Rade, J. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.650 · Cited by 93
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura
Jilma‐Stohlawetz, P., Gilbert, J., Gorczyca, M. E., Knöbl, P., & Jilma, B. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0069 · Cited by 89
Self-citation
Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteers
Fontana, P., Nolli, S., Reber, G., & de Moerloose, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01867.x · Cited by 89
Effect of Live-Fire Training Drills on Firefighters’ Platelet Number and Function
Smith, D. L., Petruzzello, S. J., Goldstein, E., Ahmad, U., Tangella, K. V., Freund, G. G., & Horn, G. P. (2011) · Prehospital Emergency Care · doi:10.3109/10903127.2010.545477 · Cited by 94
The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients
Gori, A. M., Cesari, F., Marcucci, R., Giusti, B., Paniccia, R., Antonucci, E., Gensini, G. F., & Abbate, R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.001 · Cited by 87
Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: A 6 months prospective study
Gianetti, J., Parri, M. S., Sbrana, S., Paoli, F., Maffei, S., Paradossi, U., Berti, S., Clerico, A., & Biagini, A. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.10.011 · Cited by 87
Platelet hyperreactivity generalizes to multiple forms of stimulation
Yee, D. L., Bergeron, A. L., Sun, C. W., DONG, J. ‐., & Bray, P. F. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02089.x · Cited by 83
Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation
Chan, H., Ke, L., Chu, C., Lee, A., Shen, M., Crúz, M. A., Hsu, J., Cheng, K., Chan, H., Lu, J. X., et al. (2013) · Blood · doi:10.1182/blood-2013-05-504639 · Cited by 82
Platelet count and function at high altitude and in high-altitude pulmonary edema
Lehmann, T., Mairbäurl, H., Pleisch, B., Maggiorini, M., Bärtsch, P., & Reinhart, W. H. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00991.2005 · Cited by 82
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients
Belfiori, B., Petito, E., Guglielmini, G., Malincarne, L., Mezzasoma, A., Sebastiano, M., Conti, V., Giannini, S., Bonora, S., Baldelli, F., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0504 · Cited by 81
Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
Kubica, J., Kubica, A., Jilma, B., Adamski, P., Hobl, E., Navarese, E. P., Siller-Matula, J. M., Dąbrowska, A. M., Fabiszak, T., Koziński, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.077 · Cited by 80
Self-citation
Endothelial and platelet function alterations in HIV-infected patients
Gresele, P., Falcinelli, E., Sebastiano, M., & Baldelli, F. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.022 · Cited by 76
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention
Niccoli, G., Giubilato, S., Russo, E., Spaziani, C., Leo, A. D., Porto, I., Leone, A. M., Burzotta, F., Riondino, S., Pulcinelli, F. M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn325 · Cited by 72
Targeting von Willebrand factor and platelet glycoprotein Ib receptor
Firbas, C., Siller-Matula, J. M., & Jilma, B. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.154 · Cited by 71
Self-citation
Platelet Hyperreactivity: Predictive and Intrinsic Properties
Bray, P. F. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.06.002 · Cited by 69
Platelet function and HIV: a case–control study
Satchell, C. S., Cotter, A. G., O’Connor, E., Peace, A. J., Tedesco, A. F., Clare, A., Lambert, J. S., Sheehan, G. J., Kenny, D. J., & Mallon, P. W. G. (2010) · AIDS · doi:10.1097/qad.0b013e328336098c · Cited by 67
The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediatedex vivoplatelet function in acute myocardial infarction
Spiel, A. O., Mayr, F., Ladani, N., Wagner, P., Schaub, R. G., Gilbert, J. C., & Jilma, B. (2009) · Platelets · doi:10.1080/09537100903085927 · Cited by 66
Self-citation
CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction
Zagorodnikova, K., Burbello, A., Афанасьевна, Б. С., Babak, S., Bergman, U., & Bertilsson, L. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0525-3 · Cited by 62
Comparison of Different Methods to Evaluate the Effect of Aspirin on Platelet Function in High-Risk Patients With Ischemic Heart Disease Receiving Dual Antiplatelet Treatment
Paniccia, R., Antonucci, E., Gori, A. M., Marcucci, R., Poli, S., Romano, E., Valente, S., Giglioli, C., Fedi, S., Gensini, G. F., et al. (2007) · American Journal of Clinical Pathology · doi:10.1309/0g1pej00j8kp8357 · Cited by 61
Aspirin resistance associated with HbA1c and obesity in diabetic patients
Cohen, H. W., Crandall, J. P., Hailpern, S. M., & Billett, H. H. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.05.002 · Cited by 57
Role of von Willebrand factor in vascular disease
Paulinska, P., Spiel, A. O., & Jilma, B. (2009) · Hämostaseologie · doi:10.1055/s-0037-1616936 · Cited by 57
Self-citation
Peri-Procedural Platelet Function and Platelet Inhibition in Percutaneous Coronary Intervention
Kereiakes, D. J., & Gurbel, P. A. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.01.005 · Cited by 56
Assessment of platelet function in the laboratory
Harrison, P. (2009) · Hämostaseologie · doi:10.1055/s-0037-1616935 · Cited by 55
Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts
Barrabés, J. A., Inserte, J., Mirabet, M., Quiroga, A. G., Hernando, V., Figueras, J., & David Garcia-dorado, A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0440 · Cited by 55
Antiplatelet drug nonresponsiveness
Gladding, P. A., Webster, M. W. I., Ormiston, J., Olsen, S., & White, H. D. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.034 · Cited by 53
Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients
Gong, D., Zhang, L., Zhang, Y., Wang, F., Zhao, Z., & Zhou, X. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.09.002 · Cited by 52
Cross validation of the Multiple Electrode Aggregometry
Siller-Matula, J. M., Gouya, G., Wolzt, M., & Jilma, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0669 · Cited by 51
Self-citation
Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease
Müller, K., Aichele, S., Herkommer, M., Bigalke, B., Stellos, K., Htun, P., Fateh‐Moghadam, S., May, A. E., Flather, M. D., Gawaz, M., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.023 · Cited by 51
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
Dannenberg, L., Zikeli, D., Benkhoff, M., Ahlbrecht, S., Kelm, M., Levkau, B., & Polzin, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107584 · Cited by 47
Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis
Swillo, R. E., Morgan, G., Leik, C. E., Brooks, J., Shaw, G. D., Schaub, R. G., Crandall, D. L., Vlasuk, G. P., & Hennan, J. K. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-09-0640 · Cited by 48
Partial Inhibition of Platelet Thromboxane A2 Synthesis by Aspirin Is Associated With Myonecrosis in Patients With ST-Segment Elevation Myocardial Infarction
Vallés, J., Santos, M. T. B. R., Fuset, M. P., Moscardó, A., Ruano, M., Pérez, F., Piñón, M., Breña, S., & Aznar, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.058 · Cited by 47
Variation and importance of aspirin resistance in patients with known cardiovascular disease
Poulsen, T. S., Kristensen, S. R., Korsholm, L., Haghfelt, T. H., Jørgensen, B., Licht, P. B., & Mickley, H. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.022 · Cited by 46
Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial
Ubaid, S., Ford, T. J., Berry, C., Murray, H. M., Wrigley, B., Khan, N., Thomas, M. R., Armesilla, A. L., Townend, J., Khogali, S., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1688789 · Cited by 45
White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for ST-segment elevation myocardial infarction
Çiçek, G., Açi̇kgöz, S. K., Yayla, Ç., Kundi, H., & İleri, M. (2016) · Cardiology Journal · doi:10.5603/cj.a2016.0001 · Cited by 43
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation
Höetzenecker, K., Assinger, A., Lichtenauer, M., Mildner, M., Schweiger, T., Starlinger, P. P., András, J., Berényi, E. L., Pávó, N., Zimmermann, M., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0292-2 · Cited by 40
Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome
Wang, T. Y., White, J. A., Tricoci, P., Giugliano, R. P., Zeymer, U., Harrington, R. A., Montalescot, G., James, S. K., de Werf, F. V., Armstrong, P. W., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.958041 · Cited by 40
Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction
Hartopo, A. B., Puspitawati, I., Gharini, P. P. R., & Setianto, B. Y. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59926 · Cited by 45
Randomised trial to compare a protective effect of Clopidogrel Versus TIcagrelor on coronary Microvascular injury in ST-segment Elevation myocardial infarction (CV-TIME trial)
Park, S., Lee, M., Baek, Y., Kwon, S., Shin, S., Woo, S., Kim, D., Kwan, J., & Park, K. S. (2016) · EuroIntervention · doi:10.4244/eijv12i8a159 · Cited by 39
Acute coronary syndrome is associated with a substantial change in the platelet lipidome
Harm, T., Bild, A., Dittrich, K., Goldschmied, A., Nestele, J. A., Chatterjee, M., Fu, X., Kolb, K., Castor, T., Borst, O., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab238 · Cited by 40
Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia
Derhaschnig, U., Schweeger-Exeli, I., Marsik, C. L., Cardona, F., Minuz, P., & Jilma, B. (2010) · Platelets · doi:10.3109/09537101003735572 · Cited by 39
Self-citation
Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease
Peace, A. J., Tedesco, A. F., FOLEY, D. P., Dicker, P., Berndt, M. C., & Kenny, D. J. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03157.x · Cited by 39
Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease?
Carbone, M. G., Pagni, G., Tagliarini, C., Imbimbo, B. P., & Pomara, N. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101420 · Cited by 39
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy
Smit, J. J. J., van Werkum, J. W., ten Berg, J. M., Slingerland, R. J., Ottervanger, J. P., Heestermans, T. A. A. C. M., Dill, T., Hamm, C. W., Hof, A. W. J. V. ’., & on behalf of the Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) trial investigators (2010) · Heart · doi:10.1136/hrt.2010.201889 · Cited by 38
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment–Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention
Vlachojannis, G. J., Wilschut, J., Vogel, R. F., Lemmert, M. E., Delewi, R., Diletti, R., van der Waarden, N. W. P. L., Nuis, R.-J. M., Paradies, V., Alexopoulos, D. K., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.051532 · Cited by 38
Platelet hyper-function in acute coronary syndromes
Harrison, P., Mackie, I. J., Mathur, A., Robinson, M. S. C., Hong, Y., Erusalimsky, J. D., Machin, S. J., & Martin, J. F. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000187252.09759.ba · Cited by 38
Usefulness of Pretreatment With High-Dose Clopidogrel in Patients Undergoing Primary Angioplasty for ST-Elevation Myocardial Infarction
Fefer, P., Hod, H., Hammerman, H., Segev, A., Beinart, R., Boyko, V., Behar, S., & Matetzky, S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.013 · Cited by 38
Aspirin Resistance
Mansour, K., Taher, A. T., Musallam, K. M., & Alam, S. (2009) · Advances in Hematology · doi:10.1155/2009/937352 · Cited by 39
Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen
Tunjungputri, R. N., van der Ven, A. J. A. M., Schönsberg, A., Mathan, T. S. M., Koopmans, P. J., Roest, M., Fijnheer, R., de Groot, P. G., & de Mast, Q. (2014) · AIDS · doi:10.1097/qad.0000000000000415 · Cited by 38
Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions
Maden, O., Kaçmaz, F., Selçuk, H., Selçuk, M. T., Aksu, T., Tüfekçioğlu, O., Senen, E. K., Balbay, Y., & İlkay, E. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70090-x · Cited by 36
Platelet function in clinically healthy cats and cats with hypertrophic cardiomyopathy: analysis using the Platelet Function Analyzer‐100
Jandrey, K. E., Norris, J. W., MacDonald, K. A., Kittleson, M. D., & Tablin, F. (2008) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2008.00062.x · Cited by 36
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry
Diehl, P., Schnabel, K., Weik, P., Zhou, Q., Bode, C., Moser, M., & Olivier, C. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0508 · Cited by 35
Human Genome-Wide Association and Mouse Knockout Approaches Identify Platelet Supervillin as an Inhibitor of Thrombus Formation Under Shear Stress
Edelstein, L. C., Luna, E. J., Gibson, I. B., Bray, M. S., Jin, Y., Kondkar, A. A., Nagalla, S., Hadjout-Rabi, N., Smith, T. C., Covarrubias, D., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.091462 · Cited by 34
Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy
Christie, D. J., Kottke‐Marchant, K., & Gorman, R. T. (2008) · Platelets · doi:10.1080/09537100701504095 · Cited by 34
Discrepant coagulation profile in HIV infection
Haugaard, A. K., Lund, T. T., Birch, C., Rönsholt, F. F., Trøseid, M., Ullum, H., Gerstoft, J., Johansson, P. I., Nielsen, S. D., & Ostrowski, S. R. (2013) · AIDS · doi:10.1097/01.aids.0000432462.21723.ed · Cited by 34
Platelet Activity is a Biomarker of Cardiac Necrosis and Predictive of Untoward Clinical Outcomes in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Stenting
Yip, H., Chang, L., Sun, C., Chen, M., Yang, C., Hung, W., Hsieh, Y., Fang, C.-Y., Hang, C., Wu, C., et al. (2005) · Circulation Journal · doi:10.1253/circj.70.31 · Cited by 33
Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting
Stimpfle, F., Karathanos, A., Droppa, M., Metzger, J. C., Rath, D., Müller, K., Tavlaki, E., Schäffeler, E., Winter, S., Schwab, M. G., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.006 · Cited by 32
Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation*
Spiel, A. O., Frossard, M., Mayr, F., Kliegel, A., Janata, A., Uray, T., Wandaller, C., Sterz, F. R., & Jilma, B. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181962cb9 · Cited by 32
Self-citation
An Asian Validation of the TIMI Risk Score for ST-Segment Elevation Myocardial Infarction
Selvarajah, S., Fong, A. Y. Y., Selvaraj, G., Haniff, J., Uiterwaal, C. S. P. M., & Bots, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040249 · Cited by 31
Platelet function testing in clinical diagnostics
Rechner, A. R. (2010) · Hämostaseologie · doi:10.5482/ha-1133 · Cited by 30
Baseline platelet reactivity in acute myocardial infarction treated with primary angioplasty—Influence on myocardial reperfusion, left ventricular performance, and clinical events
Huczek, Z., Filipiak, K. J., Kochman, J., Piątkowski, R., Grabowski, M., Roik, M. F., Małek, Ł. A., Jaworski, P., & Opolski, G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.03.021 · Cited by 30
FACTORS ASSOCIATED WITH ASPIRIN RESISTANCE IN PATIENTS PREMEDICATED WITH ASPIRIN AND CLOPIDOGREL FOR ENDOVASCULAR NEUROSURGERY
Reavey-Cantwell, J. F., Fox, W. C., Reichwage, B. D., Fautheree, G. L., Velat, G. J., Whiting, J. H., Chi, Y., & Hoh, B. L. (2009) · Neurosurgery · doi:10.1227/01.neu.0000341904.39691.2f · Cited by 28
Cilostazol-Based Triple Antiplatelet Therapy Compared to Dual Antiplatelet Therapy in Patients with Coronary Stent Implantation: A Meta-Analysis of 5,821 Patients
Geng, D.-F., Liu, M., Jin, D., Wu, W., Deng, J., & Wang, J. (2012) · Cardiology · doi:10.1159/000338812 · Cited by 27
Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest
Zarà, M., Campodonico, J., Cosentino, N., Biondi, M. L., Amadio, P., Milanesi, G., Assanelli, E. M., Cerri, S., Biggiogera, M., Sandrini, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158065 · Cited by 29
Relationship of admission haematological indices with infarct-related artery patency in patients with acute ST-segment elevation myocardial infarction treated with primary angioplasty
Maden, O., Kaçmaz, F., Selçuk, M. T., Selçuk, H., Metin, F., Tüfekçioğlu, O., Atak, R., Balbay, Y., & İlkay, E. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282f0eecb · Cited by 27
Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial
Spiel, A. O., Derhaschnig, U., Schwameis, M., Bartko, J., Siller-Matula, J. M., & Jilma, B. (2012) · Clinical Science · doi:10.1042/cs20120194 · Cited by 27
Self-citation
Amperometric myeloperoxidase immunoassay based on the use of CuPdPt nanowire networks
Wen, Y., Yuan, J., Chen, J., Zhao, Y., Niu, Y., & Yu, C. (2017) · Microchimica Acta · doi:10.1007/s00604-017-2563-y · Cited by 26
Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trial
Tang, Y., Hasan, F., Giordano, F. J., Pfau, S., Rinder, H. M., & Katz, S. D. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.032 · Cited by 26
Mean Platelet Volume and Extent and Complexity of Coronary Artery Disease in Diabetic and Nondiabetic Patients With ST Elevation Myocardial Infarction
Şahin, D. Y., Gür, M., Elbasan, Z., Özdoğru, İ., Uysal, O. K., Kıvrak, A., Gözübüyük, G., Türkoğlu, C., Özkan, B., & Çaylı, M. (2012) · Angiology · doi:10.1177/0003319712460423 · Cited by 25
Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: The Harmonizing Outcomes with Revascularization and Stents in AMI (HORIZONS-AMI) trial
Brener, S. J., Cristea, E., Mehran, R., Dressler, O., Lansky, A. J., & Stone, G. W. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.08.022 · Cited by 25

Authors: Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., & Jilma, B.
Affiliations: University of Vienna (AT)
ORCID: Leitner, Judith M.
Hsieh, Kety
Losert, Heidrun
Domanovits, Hans
Schreiber, Wolfgang
Jilma, Bernd
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-09-14
Volume: 110
Issue: 11
Pages: 1392-1397
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000141575.92958.9c
OpenAlex: W2156637699
Cited by: 254
References: 36
Citations by year: 2026: 2 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 6 · 2013: 10 · 2012: 19
FWCI: 13.10
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords: platelet function, acute myocardial infarction, ST-elevation myocardial infarction, platelet function analyzer, high shear rate, von Willebrand factor, platelet hyperreactivity, myocardial injury, creatine kinase-MB, troponin T, risk stratification, acute coronary syndrome
MeSH terms: Clopidogrel, Abciximab, Tirofiban, Eptifibatide, Adenosine Diphosphate, Aged, Antibodies, Monoclonal, Anticoagulants, Aspirin, Cardiovascular Agents, Collagen, Female, Humans, Immunoglobulin Fab Fragments, Leukocyte Count, Male, Middle Aged, Myocardial Infarction, Myocardium, Necrosis, Peptides, Platelet Aggregation Inhibitors, Platelet Function Tests, Predictive Value of Tests, Prospective Studies, Ticlopidine, Tyrosine, von Willebrand Factor, Platelet Activation, Comorbidity, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks